adjuvant News
Most Popular adjuvant Story
Iomai gets boost in bird flu vaccine adjuvant study
In a Phase I/II trial, three out of every four people in a study of 500 people using an adjuvant patch developed by Iomai achieved a protective immune response after a single dose. That compares to... Read more...
Latest Headlines
- February 4, 2010
- January 12, 2010
- November 12, 2009
- September 25, 2008
- March 27, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
